August 1, 2023

Zenas BioPharma Announces Publication of Phase 2 Study of Obexelimab, an Investigational Treatment for IgG4-Related Disease (IgG4-RD), in The Lancet Rheumatology

Study found obexelimab produced rapid, strong, and sustained clinical improvement, including complete clinical remission, in most patients with active IgG4-RD Results support the continued development of obexelimab for the treatment of IgG4-RD and potentially other B cell-mediated autoimmune conditions WALTHAM,

Read More

HM King thanked by Belarusian President

His Majesty King Hamad bin Isa Al Khalifa received a cable of thanks from Belarusian President Alexander Lukashenko, in response to to the congratulatory cable sent by HM the King on his country’s Independence Day.Source: Bahrain News Agency

Read More

Speaker praises government’s housing initiatives

Ahmed bin Salman Al Musallam, Speaker of the Council of Representatives, has praised the directives of His Majesty King Hamad bin Isa Al Khalifa to achieve citizens’ aspirations and support the national development process.He commended the order of Hi…

Read More